Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BLSA - BCLS Acquisition Corp - Class A


Previous close
10.035
0   0%

Share volume: 0
Last Updated: Wed 26 Oct 2022 06:00:00 AM CEST

PREVIOUS CLOSE
CHG
CHG%

$10.04
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$10.04
P/E Ratio 
0.00
DAY RANGE
$10.03 - $10.04
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
14.863 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO:
Region: US
Website: bclsacquisitioncorp.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

BCLS Acquisition Corp. is a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses or entities. While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, it intends to pursue investments, primarily based in North America and Europe and selectively in other geographies, including Asia and emerging markets, in biopharmaceutical, specialty pharmaceutical, medical device, diagnostics and enabling life science technology companies. The Company is sponsored by an affiliate of Bain Capital Life Sciences, a leading life sciences investment manager.

Recent news